abstract |
The techniques provided herein generally relate to novel fusion proteins suitable as human and / or animal vaccines against Apicomplexa parasites or pathogens. In particular, the present disclosure includes P. falciparum, P. vivax, P. malariae, Oval malaria (P. ovale) and two-day The present invention relates to a novel fusion protein as a vaccine base against Plasmodium parasites including P. knowlesi. |